$TECH News

What You Need to Know Ahead of Bio-Techne’s Earnings Release

Bio-Techne opens GMP small molecule facility in Bristol, UK

Bio-Techne Expands Global GMP Manufacturing Network with New Bristol Facility to Advance Scalable Cell Therapy Development

Bio-Techne Opens New Bristol Facility

Insider Activity Update: John L Higgins Executes Options Exercise, Resulting In $751K At Bio-Techne

INCY or TECH: Which Is the Better Value Stock Right Now?

Bio-Techne (TECH) Shareholders Approve the Merck KGaA Takeover and Reject the Pay Package

Robert V Baumgartner Exercises Options, Realizes $754K

Is Bio-Techne Stock Outperforming the Nasdaq?

3 Reasons to Sell TECH and 1 Stock to Buy Instead

Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany

Bio-Techne Receives Shareholders' Approval For Proposed Acquisition By Merck KGaA

Bio-Techne Opens New Customer Experience Center in Düsseldorf to Accelerate Scientific Discovery and Customer Collaboration

Bio Techne (TECH) And The Valuation Case Behind Its Recent Rebound

Why Is Techne (TECH) Down 0.1% Since Last Earnings Report?

Bio-Techne Achieves Science Based Targets Validation and Reports Significant Progress Toward Climate Goals

Bio-Techne Announces SBTi Validation Of 70% Scope 1 & 2 Emissions Reduction Target By FY2031 And Supplier Engagement Commitment, Reporting Significant Operational Emissions Cuts In FY2026

Winners And Losers Of Q2: Bio-Techne (NASDAQ:TECH) Vs The Rest Of The Research Tools & Consumables Stocks

Is Wall Street Bullish or Bearish on Bio-Techne Stock?

Wells Fargo Downgrades Bio-Techne to Equal-Weight, Raises Price Target to $73